Nvidia’s Bold Move: Tackling Tech’s $1 Trillion Crisis

Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%. Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with …

Find out details on these three critical Nvidia partners immediately.

Henry Wadsworth McGee, III net worth and biography

Henry McGee, III Biography and Net Worth

Director of Cencora

Henry Wadsworth McGee III serves as Independent Director of the Company. He is a Senior Lecturer at Harvard Business School, a position he has held since July 2013. From April 2013 to August 2013, Mr. McGee served as a Consultant at HBO Home Entertainment. Previously, Mr. McGee served as President of HBO Home Entertainment from 1995 until his retirement in March 2013. He served as Senior Vice President, Programming, HBO Video, from 1988 to 1995 and prior to that, Mr. McGee served in leadership positions in various divisions of HBO. Mr. McGee is the former President of the Alvin Ailey Dance Theater Foundation and the Film Society of Lincoln Center. He has served on the Boards of the Sundance Institute, the Public Theater, Save the Children and the Time Warner Foundation. He is currently a member of the Board of Tegna Inc., the Pew Research Center and the Black Filmmaker Foundation. He was recognized by Savoy Magazine in 2016 and 2017 as a member of the Power 300 list of the Most Influential Black Corporate Directors. In 2018, the National Association of Corporate Directors named Mr. McGee to the Directorship 100, the organization's annual recognition of the country's most influential boardroom members.

What is Henry Wadsworth McGee, III's net worth?: The estimated net worth of Henry Wadsworth McGee, III is at least $2.58 million as of March 5th, 2021. Mr. McGee, III owns 11,487 shares of Cencora stock worth more than $2,581,933 as of December 23rd. This net worth evaluation does not reflect any other assets that Mr. McGee, III may own. Learn More about Henry Wadsworth McGee, III's net worth.
How do I contact Henry Wadsworth McGee, III?: The corporate mailing address for Mr. McGee, III and other Cencora executives is 1300 MORRIS DRIVE, CHESTERBROOK PA, 19087. Cencora can also be reached via phone at (610) 727-7000 and via email at [email protected]. Learn More on Henry Wadsworth McGee, III's contact information.
Has Henry Wadsworth McGee, III been buying or selling shares of Cencora?: Henry Wadsworth McGee, III has not been actively trading shares of Cencora within the last three months. Most recently, Henry Wadsworth Mcgee III sold 5,801 shares of the business's stock in a transaction on Friday, March 5th. The shares were sold at an average price of $105.01, for a transaction totalling $609,163.01. Following the completion of the sale, the director now directly owns 11,487 shares of the company's stock, valued at $1,206,249.87. Learn More on Henry Wadsworth McGee, III's trading history.
Who are Cencora's active insiders?: Cencora's insider roster includes Silvana Battaglia (EVP), Elizabeth Campbell (EVP), John Chou (EVP), Gina Clark (EVP), Gina Clark (EVP), Steven Collis (CEO), Leslie Donato (EVP), Leslie Donato (EVP), Jeffrey Finnin (CFO), Juan Font (SVP), Jane Henney, MD (Director), Mark Jones (CAO), Maile Kaiser (SVP), Michael Koehler (Director), Lazarus Krikorian (CAO), Aleksandra Krusko (SVP), Robert Mauch (EVP), Robert Mauch (COO), Derek McCandless (SVP), Henry McGee, III (Director), Steven Smith (CRO), Paul Szurek (CEO), and Brian Warren (SVP). Learn More on Cencora's active insiders.
Are insiders buying or selling shares of Cencora?: During the last year, Cencora insiders bought shares 1 times. They purchased a total of 500 shares worth more than $109,290.00. During the last year, insiders at the sold shares 14 times. They sold a total of 10,720,564 shares worth more than $2,508,778,594.19. The most recent insider tranaction occured on November, 25th when Chairman Steven H Collis sold 50,000 shares worth more than $12,198,500.00. Insiders at Cencora own 15.8% of the company. Learn More about insider trades at Cencora.
Information on this page was last updated on 11/25/2024.

Henry Wadsworth McGee, III Insider Trading History at Cencora

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/5/2021	Sell	5,801	$105.01	$609,163.01	11,487
7/11/2019	Sell	10,585	$91.97	$973,502.45	24,510
9/21/2016	Sell	3,351	$82.10	$275,117.10	10,901
9/15/2015	Sell	27,592	$105.00	$2,897,160.00	8,253
11/4/2014	Sell	25,109	$87.64	$2,200,552.76
1/6/2014	Sell	9,449	$69.62	$657,839.38	10,034

Henry Wadsworth McGee, III Buying and Selling Activity at Cencora

Cencora Company Overview

Cencora, Inc. sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals primarily in Europe; and provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

Today's Range

Now: $224.77

$224.75

$227.28

50 Day Range

MA: $239.00

$224.81

$251.60

2 Week Range

Now: $224.77

$202.43

$253.27

Volume

157,249 shs

Average Volume

1,383,998 shs

Market Capitalization

$43.44 billion

P/E Ratio

29.93

Dividend Yield

0.97%

Beta

0.45